D. Witzigmann
Molecular Biology · 2015–2022
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 94 citations into it
- Biomaterials — 39 citations into it
- Biomedical Engineering — 28 citations into it
Whom D. Witzigmann trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from D. Witzigmann's perspective
Ordered by how strongly the researchers D. Witzigmann trusts endorse each paper. Same corpus, a different order for every researcher.
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. (Molecular Therapy)
- mRNA-based therapeutics — developing a new class of drugs (Nature reviews. Drug discovery)
- Pharmacokinetics and biodistribution of nanoparticles. (Molecular Pharmaceutics)
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. (Molecular Therapy)
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling (Nature Biotechnology)
- Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
- The many pathways of RNA degradation. (Cell)
- Freeze-drying of nanoparticles: formulation, process and storage considerations. (Advanced Drug Delivery Reviews)
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (New England Journal of Medicine)
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. (Nano letters (Print))
Their papers
- Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. (2015) — 1,667 citations
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs (2019) — 1,342 citations
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability (2021) — 1,255 citations
- The role of lipid components in lipid nanoparticles for vaccines and gene therapy (2022) — 966 citations
- The current landscape of nucleic acid therapeutics (2021) — 1,072 citations